Bailrigg Immunodiagnostics Limited in Lancaster, LA1 3FR

Description

Data updated on: 01-11-2023

This business operates as Bailrigg Immunodiagnostics Limited. This firm first started 8 years ago and was registered with 10663923 as its reg. no. This particular registered office of the firm is registered in Lancaster. You may find them at 15 Cassidy Drive. It debuted under the business name Ebiogen Id, but for the last eight years has operated under the business name Bailrigg Immunodiagnostics Limited. This company's Standard Industrial Classification Code is 72110 which means Research and experimental development on biotechnology. Bailrigg Immunodiagnostics Ltd released its latest accounts for the financial year up to 2021-03-31. The most recent confirmation statement was released on 2023-03-09.

Presently, the firm is overseen by a single managing director: Mukesh K., who was assigned to lead the company six years ago. Since Friday 10th March 2017 Rashmi M., had performed assigned duties for the firm till the resignation in 2019.

Previous company's names
Bailrigg Immunodiagnostics Limited 2017-10-09
Ebiogen Id Limited 2017-03-10

Financial data based on annual reports

Profit & Loss
Date of Accounts	2018-03-31	2019-03-31	2020-03-31	2021-03-31	2022-09-28	2023-09-25
Currency

Balance Sheet
Cash Bank On Hand	7 935	19 103	267	7 200
Current Assets	12 710	30 893	5 385	11 540	1 050	1 025
Debtors	4 775	11 790	5 118	4 340
Net Assets Liabilities			2 940	1 380	6 705	6 360
Other Debtors	4 775	11 790	5 118	4 340

Other Financial Data
Bank Borrowings Overdrafts				7 500
Creditors	402	6 972	2 445	2 660	1 665	1 765
Net Current Assets Liabilities	12 308	23 921	2 940	8 880	615	740
Number Shares Issued Fully Paid	6 600
Other Creditors	402	1 152	1 497	1 472
Par Value Share	1
Trade Creditors Trade Payables		5 820	948	1 188
Fixed Assets					950	1 050
Total Assets Less Current Liabilities				8 880	335	310

Company staff

Mukesh K.

Role: Director

Appointed: 01 May 2019

Latest update: 12 May 2025

People with significant control

Executives with significant control over the firm are: Rashmi M. owns 1/2 or less of company shares and has 1/2 or less of voting rights. Mukesh K. owns over 1/2 to 3/4 of company shares and has over 1/2 to 3/4 of voting rights.

Rashmi M.

Notified on 1 June 2017

Nature of control:

1/2 or less of voting rights

right to manage directors

1/2 or less of shares

Mukesh K.

Notified on 14 August 2017

Nature of control:

over 1/2 to 3/4 of shares

over 1/2 to 3/4 of voting rights

right to manage directors

Rashmi M.

Notified on 10 March 2017

Ceased on 14 August 2017

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Accounts Documents

Account next due date	27 November 2023
Account last made up date	31 March 2021
Confirmation statement next due date	23 March 2024
Confirmation statement last made up date	09 March 2023

Annual Accounts
Start Date For Period Covered By Report	2017-03-10
End Date For Period Covered By Report	2018-03-31
Annual Accounts
Start Date For Period Covered By Report	2018-04-01
End Date For Period Covered By Report	2019-03-31
Annual Accounts
Start Date For Period Covered By Report	2019-04-01
End Date For Period Covered By Report	2020-03-31
Annual Accounts
Start Date For Period Covered By Report	2020-04-01
End Date For Period Covered By Report	2021-03-31
Annual Accounts
Start Date For Period Covered By Report	2021-04-01
End Date For Period Covered By Report	2022-09-28
Annual Accounts
Start Date For Period Covered By Report	2022-09-29
End Date For Period Covered By Report	2023-09-25

Bailrigg Immunodiagnostics Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Mukesh K.

Rashmi M.

People with significant control

Rashmi M.

Mukesh K.

Rashmi M.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age